Facultad de Medicina (FM)
Centro académico
David Geffen School of Medicine at UCLA
Los Ángeles, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von David Geffen School of Medicine at UCLA (53)
2024
-
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial
Gynecologic Oncology, Vol. 184, pp. 168-177
-
Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)
Blood cancer discovery, Vol. 5, Núm. 1, pp. 21-33
2023
-
Association of Multiple High-Risk Factors on Observed Outcomes in Real-World Patients With Advanced Ovarian Cancer Treated With First-Line Therapy
JCO clinical cancer informatics, Vol. 7, pp. e2200189
-
Clinical Usefulness of Prostate-specific Membrane Antigen-ligand Positron Emission Tomography/Computed Tomography for the Detection of Prostate Cancer Biochemical Recurrence after Primary Radiation Therapy in Patients with Prostate-specific Antigen Below the Phoenix Threshold: Systematic Review and Meta-analysis
Clinical Oncology, Vol. 35, Núm. 12, pp. e676-e688
-
Combination immunotherapy for hepatocellular carcinoma
Journal of Hepatology, Vol. 79, Núm. 2, pp. 506-515
-
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)
Leukemia
-
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Nature Medicine, Vol. 29, Núm. 6, pp. 1370-1378
-
Real-World Outcomes Following First-Line Treatment in Patients with Advanced Ovarian Cancer with Multiple Risk Factors for Disease Progression who Received Maintenance Therapy or Active Surveillance
Oncology and Therapy, Vol. 11, Núm. 2, pp. 245-261
-
The 5-HT1F receptor as the target of ditans in migraine — from bench to bedside
Nature Reviews Neurology, Vol. 19, Núm. 8, pp. 489-505
2022
-
Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy (Nature Medicine, (2022), 28, 3, (557-567), 10.1038/s41591-022-01696-4)
Nature Medicine
-
Central Role of the Antigen-Presentation and Interferon-γ Pathways in Resistance to Immune Checkpoint Blockade
Annual Review of Cancer Biology, Vol. 6, pp. 85-102
-
Global Circumferential and Radial Strain Among Patients With Immune Checkpoint Inhibitor Myocarditis
JACC: Cardiovascular Imaging, Vol. 15, Núm. 11, pp. 1883-1896
-
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer A Patient-Level Data Analysis of 3 Cohorts
JAMA Oncology, Vol. 8, Núm. 3
-
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
The Lancet Oncology, Vol. 23, Núm. 1, pp. 77-90
-
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy
Nature Medicine, Vol. 28, Núm. 3, pp. 557-567
2021
-
Autoimmune diseases are linked to type IIb autoimmune chronic spontaneous urticaria
Allergy, Asthma and Immunology Research, Vol. 13, Núm. 3
-
Comparison of Multimodal Therapies and Outcomes among Patients with High-Risk Prostate Cancer with Adverse Clinicopathologic Features
JAMA Network Open, Vol. 4, Núm. 7
-
Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C
Journal of Clinical Endocrinology and Metabolism, Vol. 106, Núm. 2, pp. E660-E674
-
Five Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death-Ligand 1–Positive Advanced NSCLC
Journal of Thoracic Oncology
-
Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes
Biological Psychiatry, Vol. 89, Núm. 8, pp. 825-835